Treatment of experimental staphylococcal endocarditis due to a strain with reduced susceptibility in vitro to vancomycin: efficacy of ampicillin-sulbactam
- PMID: 10508047
- PMCID: PMC89523
- DOI: 10.1128/AAC.43.10.2565
Treatment of experimental staphylococcal endocarditis due to a strain with reduced susceptibility in vitro to vancomycin: efficacy of ampicillin-sulbactam
Abstract
We evaluated several 3-day antimicrobial regimens in the treatment of experimental endocarditis caused by an oxacillin-resistant Staphylococcus aureus strain exhibiting intermediate susceptibility in vitro to vancomycin (VISA). Neither vancomycin alone nor trovafloxacin exhibited in vivo efficacy; addition of amikacin to vancomycin yielded a modest in vivo effect. In contrast, the combination of ampicillin and sulbactam was highly effective in vivo, causing a mean decrease in VISA vegetation densities of >5 log(10) CFU/g versus those of untreated controls.
Figures

Similar articles
-
Ampicillin-sulbactam is effective in prevention and therapy of experimental endocarditis caused by beta-lactamase-producing coagulase-negative staphylococci.Antimicrob Agents Chemother. 1996 Jan;40(1):97-101. doi: 10.1128/AAC.40.1.97. Antimicrob Agents Chemother. 1996. PMID: 8787887 Free PMC article.
-
Ampicillin, sulbactam, and rifampin combination treatment of experimental methicillin-resistant Staphylococcus aureus endocarditis in rabbits.J Infect Dis. 1995 Apr;171(4):897-902. doi: 10.1093/infdis/171.4.897. J Infect Dis. 1995. PMID: 7706817
-
Activity of ampicillin-sulbactam and oxacillin in experimental endocarditis caused by beta-lactamase-hyperproducing Staphylococcus aureus.Antimicrob Agents Chemother. 1993 Mar;37(3):507-11. doi: 10.1128/AAC.37.3.507. Antimicrob Agents Chemother. 1993. PMID: 8460919 Free PMC article.
-
[Emergence of hetero-VRSA strains in Japanese hospitals and its countermeasure].Nihon Rinsho. 1998 Oct;56(10):2699-705. Nihon Rinsho. 1998. PMID: 9796340 Review. Japanese.
-
The role of vancomycin in the treatment paradigm.Clin Infect Dis. 2006 Jan 1;42 Suppl 1:S51-7. doi: 10.1086/491714. Clin Infect Dis. 2006. PMID: 16323121 Review.
Cited by
-
Consensus Report on Diagnosis, Treatment and Prevention of Infective Endocarditis by Turkish Society of Cardiovascular Surgery (TSCVS), Turkish Society of Clinical Microbiology and Infectious Diseases (KLIMIK), Turkish Society of Cardiology (TSC), Turkish Society of Nuclear Medicine (TSNM), Turkish Society of Radiology (TSR), Turkish Dental Association (TDA) and Federation of Turkish Pathology Societies (TURKPATH) Cardiovascular System Study Group.Turk Gogus Kalp Damar Cerrahisi Derg. 2020 Jan 23;28(1):2-42. doi: 10.5606/tgkdc.dergisi.2020.01954. eCollection 2020 Jan. Turk Gogus Kalp Damar Cerrahisi Derg. 2020. PMID: 32175140 Free PMC article.
-
Influence of reduced susceptibility to glycopeptides on activities of vancomycin and teicoplanin against Staphylococcus aureus in experimental endocarditis.Antimicrob Agents Chemother. 2003 Jun;47(6):2018-21. doi: 10.1128/AAC.47.6.2018-2021.2003. Antimicrob Agents Chemother. 2003. PMID: 12760890 Free PMC article.
-
The Potential Role of Sulbactam and Cephalosporins Plus Daptomycin Against Daptomycin-Nonsusceptible VISA and H-VISA Isolates: An in Vitro Study.Antibiotics (Basel). 2019 Oct 14;8(4):184. doi: 10.3390/antibiotics8040184. Antibiotics (Basel). 2019. PMID: 31615078 Free PMC article.
-
Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications.Clin Microbiol Rev. 2010 Jan;23(1):99-139. doi: 10.1128/CMR.00042-09. Clin Microbiol Rev. 2010. PMID: 20065327 Free PMC article. Review.
-
Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis.Sci Rep. 2020 Jul 29;10(1):12689. doi: 10.1038/s41598-020-69058-z. Sci Rep. 2020. PMID: 32728110 Free PMC article.
References
-
- Bayer A S, Crowell D, Bradley D, Yih J, Norman D C. Differential antimicrobial pharmacokinetics and pharmacodynamics in right-sided versus left-sided vegetations in experimental Pseudomonas aeruginosa endocarditis. J Infect Dis. 1988;158:355–359. - PubMed
-
- Bayer A S, Lam K. Efficacy of vancomycin plus rifampin in experimental aortic valve endocarditis due to methicillin-resistant Staphylococcus aureus: in vitro-in vivo correlations. J Infect Dis. 1985;151:157–165. - PubMed
-
- Bayer A S, Norman D C. Valve-site specific pathogenetic differences between right-sided and left-sided bacterial endocarditis. Chest. 1990;98:200–205. - PubMed
-
- Bayer A S, Norman D C, Chiu C Y, Nast C. Pathogenic effects of neutropenia, monocytopenia and steroid treatment in experimental Pseudomonas endocarditis. Chemotherapy. 1989;35:278–288. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous